The rapidly spreading omicron variant (Pango lineage B.1.1.529) has been classified by WHO as a variant of concern (VOC) due to risks of potential immune escape, increased transmissibility, reduction in vaccine effectiveness, as well as increased risk for re-infections when compared to the Delta variant.
We now offer omicron variant recombinant spike protein and nucleoprotein-derived reagents for research, as well as potential antibodies for the omicron variant.
Omicron antigens
| Cat-No. | Item | Antigen | Tag | Host | Mutations |
|---|---|---|---|---|---|
| 40589-V08H26 | Omicron (B.1.1.529) | S-ECD | C-His | HEK293 | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F |
| 40589-V08B33 | Omicron (B.1.1.529) | S-ECD | C-His | Insect | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F |
| 40589-V9H3-B | Omicron (B.1.1.529) | S-ECD | C-His-AVI | HEK293 | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F |
| 40592-V08H121 | Omicron (B.1.1.529) | RBD | C-His | HEK293 | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H |
| 40592-V49H7-B | Omicron (B.1.1.529) | RBD | C-His-AVI | HEK293 | G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H |
| 40591-V08H41 | Omicron (B.1.1.529) | S1 | C-His | HEK293 | A67V, Δ69-70, T95I, G142D/Δ143-145, Δ211/L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H |
| 40588-V07E34 | Omicron (B.1.1.529) | N | N-His | E. coli | P13L, E31del, R32del, S33del, R203K, G204R |
| Cat-No. | Item | Size | Price (CHF) |
|---|---|---|---|
| C19SD-G231OH-10 | C19SD-G231OH (2019-nCoV Protein RBD (Omicron) | 10 ug | 160.00 |
| C19S1-G231OH-10 | C19S1-G231OH (2019-nCoV Protein S1 (Omicron) | 10 ug | 160.00 |
| C19SD-G231FH-10 | C19SD-G231FH - Recombinant 2019-nCoV Spike protein S1 subunit | 10 ug | 160.00 |
Antibodies for Omicron variant research
Our suppliers offer a wide range of antibodies whose immunogens do not contain any Omicron mutation sites, thus making them ideal reagents for studies of this variant. The following antibodies may detect the Omicron VOC spike protein based on immunogen sequence analysis.
| Cat. No. | Product Name | Clonality | Applications |
|---|---|---|---|
| GTX635692 | Spike RBD antibody [HL257] | Rb RecAb | WB, ICC/IF, IHC-P, ELISA, IHC-P (cell pellet) |
| GTX635656 | Spike S1 antibody [HL1] | Rb RecAb | WB, ICC/IF, ELISA, Sandwich ELISA |
| GTX635693 | Spike S2 antibody [HL237] | Rb RecAb | WB, ICC/IF, ELISA, Sandwich ELISA, IHC-P (cell pellet) |
| GTX632604 | Spike antibody [1A9] | Ms mAb | WB, ICC/IF, IHC-P, FACS, IP, ELISA, EM, Sandwich ELISA, IHC-P (cell pellet) |
| GTX135360 | Spike antibody | Rb pAb | WB, ICC/IF, ELISA, Sandwich ELISA |
| GTX135385 | Spike RBD antibody | Rb pAb | WB, ICC/IF |
| GTX135386 | Spike S2 / S2' antibody | Rb pAb | WB, ICC/IF, ELISA, Sandwich ELISA |
| 40592-MM117-100UG | SARS-CoV-2 Spike Antibody, Omicron Reactive, Mouse MAb | MAb | ELISA, Neutralization |
For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.